Colchicine therapy for hepatic murine schistosomal fibrosis: Image analysis and serological study

International Journal of Experimental Pathology

Volumn 80, Issue 1, 1999, Pages 25-34

  Badawy, Afkar A ^a   El Badrawy, Nawal M ^b   Hassan, Mona M ^b   Ebeid, Fatma A ^c  

^a Imbaba   (Egypt)

^b THEODOR BILHARZ RESEARCH INSTITUTE   (Egypt)

^c Giza   (Egypt)

Author keywords

Ag NORs; Colchicine; Cyclic AMP; DNA content; IL 2; Schistosomal liver fibrosis

Indexed keywords

COLCHICINE; COLLAGEN; DNA; INTERLEUKIN 2; PRAZIQUANTEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHROMOSOME NOR; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DNA CONTENT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; LIVER BIOPSY; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS;

ANIMALS; CELL CYCLE; COLCHICINE; COLLAGEN; DNA; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERLEUKIN-2; LIVER CIRRHOSIS; MICE; NUCLEOLUS ORGANIZER REGION; SCHISTOSOMIASIS MANSONI;

EID: 0033051486     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1999.00093.x     Document Type: Article

References (32)

1. ANASTASSAKOS C., ALEXANDER G.J., WOLSTENCROFT R.A. ET AL. (1988) Interleukin-1 and Interleukin-2 activity in chronic hepatitis B virus infection. Gastroent., 94, 995-1005.
2. ANDRADE Z.A., MEDEIRAS M.U., AZEVEDO T.M. & GUERRET S. (1990) Action of colchicine on hepatic schistosomal granuloma. Mem. Inst. Oswaldo. Cruz. 85, 79-85.
3. BADAWY A.A., BADRAWY N.M., MANSY S.S., AKL M.M., ABDEL HADY A.M., EBEID F.A. & HASSAN M.M. (1996) Evaluation of colchicine with or without praziquantel therapy in the control of hepatic fibrosis in murine schistosomiasis. Pharmacol. Res. 33, 319-325.
4. BOLARIN D.M., BAKER K. & FULLER C.G. (1987) Enzyme markers of collagen synthesis in carbon tetrachloride-induced fibrosis and during colchicine modification of CCL4-induced liver unjury. Exp. Mol. Pathol. 46, 145-152.
5. CHEEVER A.W., FINKELMAN F.D., CASPAR P., HEINY S., MACEDONIA J.G. & SHER A. (1992) Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production. J. Immunol. 148, 3244-3248.
6. DIEHL A.M., YANG S.Q., COTE P. & WAND G.S. (1992) Chronic ethanol consumption disturbs G-protein expression inhibits cyclic AMP-dependent signalling in regenerating rat liver. Hepatology. 16, 1212-1219.
7. EGAN M.J. & CROCKER J. (1992) Nucleolar organiser regions in pathology. Br. J. Cancer. 65, 1-7.
8. EMONARD H. & GRIMAUD J.A. (1989) Active and latent collagenase activity during reversal of hepatic fibrosis in murine schistosomiasis. Hepatology. 10, 77-85.
9. HARPER J.F. & BROOKER G. (1975) Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMA after acetylation by acetic anhydride in aqueous solution. J. Cyclic Nucleotide Res. 1, 207-213.
10. HENDERSON G.S., LU X., MCCURLEY T.L. & COLLEY D.G. (1992) In vivo molecular analysis of lymphokines involved in the murine response during Schistosoma mansoni infection. Il quantification of IL-4 mRNA, IFN-gamma MRNA and IL-2 mRNA levels in the granulomatous livers mesenteric lymph nodes and spleen during the course of modulation. J. Immunol. 148, 2261-2269.
11. JIANG J.W., ZHONG C.S., YU Y.F., WEI C.C. & XU Z.Y. (1990) Ultrastructural studies on effects of colchicine in treating hepatic fibrosis of schistosomal rabbits. Chung Kuo - Chi -Sheng - Chung - Hsueh - Yu - Chi - Sheng - Chung - Ping - Tsa - Chin. 8, 84-87.
12. JIANG Z., YOU D.Y., CHEN X.N. & WU J. (1992) Monitoring of serum markers for fibrosis during CCL4 induced liver damage. Effect of anti-fibrotic agents. J. Hepatol. 16, 282-289.
13. KAHALEH A.B. & LERDY E.C. (1989) Interleukin-2 in schleroderma: Correlation of serum level with extent of skin involvement and disease duration. Annl. Intern. Med. 110, 446-450.
14. KHALIL H.M., BEBARS M.A., EL-BADAWY N.M., ABDALLAH H.M., KHALIL N.M. & EL-ZAYYAT E.A. (1995) Effect of praziquantel treatment on hepatic pathology of Schistosoma mansoni experimentally infected mice. J. Egypt Soc. Parasitol. 25, 269-277.
15. KRESINA T.F., HE Q., DEGLI ESPOSTI S. & ZERN M.A. (1994) Gene expression of transforming growth factor beta 1 and extracellular matrix proteins in murine Schistosoma mansoni infection. Gastroenterology. 107, 773-789.
16. LEIGHTON J.A., BAY M.K., MALDONADO A.L., SCHENKER S. & SPEEG K.V. (1991) Colchicine clearance is impaired in alcoholic cirrhosis. Hepatology. 14, 1013-1015.
17. MANSOUR M.M., DUNN M.A. & SALAH L.A. (1988) Effect of colchicine on collagen synthesis by liver fibroblasts in murine schistosomiasis. Clin. Chim. Acta. 177, 11-20.
18. MENINO M.I., CUTRIN C. & PARAFITA M.A. (1993) Effect of colchicine on lactate production by isolated hepatocytes in rats treated with CCL4 and ethanol. Drug. Alcohol. Depend. 32, 181-185.
19. MILLER L.C. & KAPLAN M.M. (1992) Serum interleukin-2 and tumour necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am. J. Gastroenterol. 87, 465-470.
20. MONTASSER M.F., YOUNIS T.A., FAHMY I.L., SABRY N.M., EL-MONAYERHY M.S. & RASHAD M.S. (1994) Histopathological evidence for the anti-fibrogenic effect of colchicine in Schistosomiasis mansoni in mice. J. Egypt. Soc. Parasitol. 24, 155-165.
21. RAEDSCH R., STIEHL A., WALKER S., SCHERMANN J.M. & KOMMERELL B. (1992) Combined ursodeoxycholic acid plus colchicine-treatment of primary biliary cirrhosis: results of a placebo controlled double-blind study. J. Gastroenterol. 30, 55-57.
22. RAO C.V. & MEHENDALE H.M. (1991) Effect of colchicine on hepatobiliary function in CCL4 treated rats. Biochem. Pharmacol. 42, 2323-2332.
23. ROJKIND M., KERSHENOBICH D. & PEREZ TAMAYO R. (1982) Colchicine: an old drug for an ancient problem. In Proceedings of connective tissue of the normal and fibrotic human liver. Eds. U. Gerlach, G. Pott, J. Rauterberg & B. Voss. Stuttgart: Georg Theine Verlag. pp. 237-241.
24. SCHULTE E. & WITTEKIND D. (1989) Standardization of the feulgenschiff technique. Staining characteristics of pure fuchsin dyes, a cytophotometric investigation. Histochemistry, 91, 321-331.
25. SHIRO T., SEKI T., NAITOH Y., INOUE K. & OKAMOUR A. (1993) A correlation of arggrophilic nuclear orgonizer regions with stages of hepatocellular carcinoma. Cancer. 71, 44-49.
26. THEILMANN L. (1992) Colchicine in toxic liver cirrhosis and primary biliary cirrhosis. Z. Gastroenterol. 30, 40-42.
27. VIDAL B.C. (1984) Polyploidy and nuclear phenotypes in salivary glands of the rat. Biol. Cell. 50, 137-146.
28. VIDAL B.C., PLANDING W., MELLO M.L. & SCHENCK U. (1994) Quantitative evaluation of Ag NOR in liver cells high-resolation image cytometry. Anal. Cell. Pathol. 7, 27-41.
29. WARDAS M., DROZDZ M., WICHARY M. & RADWANSKA-WALA B. (1992) The fate of collagen during experimental liver lesion with corbon tetrachloride in the presence and absence of colchicine. Exp. Tox. Pathol. 44, 15-16.
30. WARNES T.W. (1991) Colchicine in primary biliary cirrhosis. Aliment. Pharmacol. 5, 321-329.
31. WARREN K.S. (1978) Hepatosplenic schistosomiasis. A great neglected disease of the liver. Gut, 19, 572-577.
32. WIED G.L., BARTELS P.M., BIBBO M., DYTCH H.E. (1989) Image analysis in quantitative cytopathology and histopathology. Human Pathology, 20, 549-571.